BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31503380)

  • 1. Cyclin D1 immunohistochemical expression and somatic mutations in canine oral melanoma.
    Zamboni C; Brocca G; Ferraresso S; Ferro S; Sammarco A; Dal Corso C; Iussich S; de Andres PJ; Martìnez de Merlo EM; Cavicchioli L; Zappulli V; Castagnaro M
    Vet Comp Oncol; 2020 Jun; 18(2):231-238. PubMed ID: 31503380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of KIT expression and KIT exon 11 mutations in canine oral malignant melanomas.
    Murakami A; Mori T; Sakai H; Murakami M; Yanai T; Hoshino Y; Maruo K
    Vet Comp Oncol; 2011 Sep; 9(3):219-24. PubMed ID: 21848624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The significance of Ki-67 proliferative index and cyclin D1 expression of dysplastic nevi in the biologic spectrum of melanocytic lesions.
    Lebe B; Pabuççuoğlu U; Ozer E
    Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):160-4. PubMed ID: 17525627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of somatic focal amplifications on chromosome 30 in canine oral melanoma.
    Prouteau A; Chocteau F; de Brito C; Cadieu E; Primot A; Botherel N; Degorce F; Cornevin L; Lagadic MA; Cabillic F; de Fornel-Thibaud P; Devauchelle P; Derrien T; Abadie J; André C; Hédan B
    Vet Comp Oncol; 2020 Jun; 18(2):214-223. PubMed ID: 31461207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic evaluation of Ki67 threshold value in canine oral melanoma.
    Bergin IL; Smedley RC; Esplin DG; Spangler WL; Kiupel M
    Vet Pathol; 2011 Jan; 48(1):41-53. PubMed ID: 21123859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCND1 amplification and cyclin D1 immunohistochemical expression in head and neck squamous cell carcinomas.
    Hanken H; Gröbe A; Cachovan G; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M
    Clin Oral Investig; 2014 Jan; 18(1):269-76. PubMed ID: 23494454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCND1 copy number increase and cyclin D1 expression in acral melanoma: a comparative study of fluorescence in situ hybridization and immunohistochemistry in a Chinese cohort.
    Liu J; Yu W; Gao F; Qi S; Du J; Ma X; Zhang Y; Zheng J; Su J
    Diagn Pathol; 2021 Jul; 16(1):60. PubMed ID: 34225728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of surgical margin, Ki-67 and cyclin D1 protein expression in grade II canine cutaneous mast cell tumor.
    Ozaki K; Yamagami T; Nomura K; Narama I
    J Vet Med Sci; 2007 Nov; 69(11):1117-21. PubMed ID: 18057825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cyclin D1 and Ki-67 in the development and prognostication of thin melanoma.
    Kaufmann C; Kempf W; Mangana J; Cheng P; Emberger M; Lang R; Kaiser AK; Lattmann E; Levesque M; Dummer R; Koelblinger P
    Histopathology; 2020 Sep; 77(3):460-470. PubMed ID: 32374893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma.
    Sathyan KM; Nalinakumari KR; Abraham T; Kannan S
    Oral Oncol; 2008 Jul; 44(7):689-97. PubMed ID: 18061526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration in E-cadherin/β-catenin expression in canine melanotic tumors.
    Han JI; Kim Y; Kim DY; Na KJ
    Vet Pathol; 2013 Mar; 50(2):274-80. PubMed ID: 22895538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fascin-1 expression in canine cutaneous and oral melanocytic tumours.
    Yamada N; Mori T; Murakami M; Noguchi S; Sakai H; Akao Y; Maruo K
    Vet Comp Oncol; 2012 Dec; 10(4):303-11. PubMed ID: 22236355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on the implications of cyclin D1 in oral carcinogenesis.
    Ramos-García P; Gil-Montoya JA; Scully C; Ayén A; González-Ruiz L; Navarro-Triviño FJ; González-Moles MA
    Oral Dis; 2017 Oct; 23(7):897-912. PubMed ID: 27973759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression and prognostic significance of MAGE-A in canine oral malignant melanoma.
    Guillén A; Stiborova K; Ressel L; Blackwood L; Finotello R; Amores-Fuster I; Jama N; Killick D
    Res Vet Sci; 2021 Jul; 137():226-234. PubMed ID: 34023546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical Expression of Cyclin D1 and Ki-67 in Primary and Metastatic Oral Squamous Cell Carcinoma.
    Nazar M; Naz I; Mahmood MK; Hashmi SN
    Asian Pac J Cancer Prev; 2020 Jan; 21(1):37-41. PubMed ID: 31983161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of p53, cyclin D1 and Ki-67 in pre-malignant and malignant oral lesions: association with clinicopathological parameters.
    Raju B; Mehrotra R; Oijordsbakken G; Al-Sharabi AK; Vasstrand EN; Ibrahim SO
    Anticancer Res; 2005; 25(6C):4699-706. PubMed ID: 16334163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 expression is associated with infiltration of inflammatory cells in oral and skin canine melanomas.
    Silveira TL; Veloso ES; Gonçalves INN; Costa RF; Rodrigues MA; Cassali GD; Del Puerto HL; Pang LY; Argyle DJ; Ferreira E
    Vet Comp Oncol; 2020 Dec; 18(4):727-738. PubMed ID: 32323423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFR, HER-2/neu, cyclin D1, p21 and p53 in correlation to cell proliferation and steroid hormone receptor status in ductal carcinoma in situ of the breast.
    Lebeau A; Unholzer A; Amann G; Kronawitter M; Bauerfeind I; Sendelhofert A; Iff A; Löhrs U
    Breast Cancer Res Treat; 2003 May; 79(2):187-98. PubMed ID: 12825853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA Expression in Formalin-Fixed, Paraffin-Embedded Samples of Canine Cutaneous and Oral Melanoma by RT-qPCR.
    Zamarian V; Catozzi C; Ressel L; Finotello R; Ceciliani F; Vilafranca M; Altimira J; Lecchi C
    Vet Pathol; 2019 Nov; 56(6):848-855. PubMed ID: 31526125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of cytoplasmic cyclin D1 expression in oral oncogenesis.
    Ramos-García P; Bravo M; González-Ruiz L; González-Moles MÁ
    Oral Dis; 2018 Mar; 24(1-2):98-102. PubMed ID: 29480608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.